Market By Transplant Type, Indication, End-user, And Geography | Forecasts 2019-2027
According to Triton, the global bone marrow transplant market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 5.13%. The market was assessed to be worth $11066.78 million in the year 2018 and is predicted to generate a revenue of approximately $17337.49 million by the year 2027. A bone marrow transplant is a process to replace damaged bone marrow with healthy stem cells. It is the fatty and soft tissue within the bones, functioning to produce the blood cells. Stem cells are also known as immature cells and are present in the bone marrow. It helps to increase various blood cells in the human body.
Bone marrow transplantation process is suggested to treat severe stages of Hodgkin and non-Hodgkin lymphomas, leukemia, aplastic and sickle cell anemia, multiple myeloma, thalassemia, etc. In the year 2015, globally more than 75,000 bone marrow transplants were performed, and the number is set to rise around 25% by the year 2020. Based on the bone marrow or stem cells source, the process of transplant is classified into conventional bone marrow transplant or peripheral stem cell transplant (PSCT). The rising advancement in the bone marrow transplant procedures and the constant researches and developments to minimize the risks and side effects is lifting the market significantly, aiming to offer improved care to the people across the globe.
Report scope can be customized per your requirements. Request For Customization
The ultimate option suggested by the doctors in critical cases of skin & bone cancer, fatal bone marrow disorder is bone marrow transplant. Therefore, it is concluded that the increasing prevalence of such fatal disorders is one of the major factor boosting the growth of the bone marrow transplant market globally. A disrupt in the functioning of the bone marrow can lead to major health issues in a human body. Moreover, unhealthy lifestyle, which involves excess alcohol or smoking addiction, unwholesome diets can also lead to the growing demand for major diseases in the body, which boost the market growth drastically.
Increase in the confidence of the patient towards the bone marrow procedure is known to be one of the prime trend witnessed in the market. This trend is attributed to the developing prognosis of the medical condition, backed by extensive research and development in bone marrow transplant. Hence, the overall bone marrow transplant market performance is expected to enhance as the advancement in the process keep getting less challenging and hi-tech.
The bone marrow transplant market report from Triton discusses the key insights regarding the industry. In addition, the market attractiveness matrix, key buying criteria, Porter's five force analysis, and market trends are also studied in the report.
The top market drivers such as the prevalence of cancer have increased worldwide, and increased federal funding are analyzed in detail in the report. Also, factors like the imbalance in the supply and demand for bone marrow transplant and ethical issues are restricting the market growth.
The key opportunities like technological inventions and reimbursement in the developed nations are expected to exhibit the growth of the market over the projected years. However, the high cost of treatment is challenging in the market growth, which is affecting the market demand negatively, especially in the emerging region.
The major geographies covered in the bone marrow transplant market are:
o North America: the United States and Canada
o Europe: United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe
o Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia Pacific
o Latin America: Brazil, Mexico and Rest of Latin America
o The Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East and Africa
The bone marrow market is segmented into:
• By transplant type:
o Autologous bone marrow transplant
o Allogeneic bone marrow transplant
• By indication:
o Multiple Myeloma
o Acute Leukemia
o Hodgkin Lymphoma
o Non-Hodgkin Lymphoma
o A solid tumor
o Other indications
• By end-users:
o Multispecialty clinics
o Hospitals
o Ambulatory Surgical Centers
The dominant companies involved in the bone marrow transplant market are Abbott Laboratories, Astellas Pharma Inc., Affymetrix Inc. (Acquired by Thermo Fisher), Diadexus Inc. (Acquired by Diazyme Laboratories), Stryker Corp., Illumina Inc., Agilent Technologies Inc., Qiagen N.V., SANOFI and Roche Diagnostics Ltd.
The strategic analysis for each of these companies in the bone marrow transplant market is covered in detail. The company market share helps to dive into the information about the key market players in this industry and their share in the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
BONE MARROW TRANSPLANT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTERS
FIVE FORCES OUTLOOK
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF RIVALRY
2.3. VENDOR
SCORECARD
2.4. KEY
BUYING CRITERIA
2.5. MARKET
TRENDS
2.6. KEY
INSIGHTS
2.7. MARKET
ATTRACTIVENESS MATRIX
2.8. MARKET
DRIVERS
2.8.1. PREVALENCE
OF CANCER HAS INCREASED WORLDWIDE
2.8.2. INCREASE
IN FEDERAL FUNDING OFFERINGS
2.9. MARKET
RESTRAINTS
2.9.1. IMBALANCE
IN THE SUPPLY AND DEMAND FOR BONE MARROW TRANSPLANT
2.9.2. ETHICAL
ISSUES
2.10.
MARKET OPPORTUNITIES
2.10.1.
TECHNOLOGICAL INVENTIONS
2.10.2.
REIMBURSEMENT
OPPORTUNITIES IN DEVELOPED NATIONS
2.11.
MARKET CHALLENGES
2.11.1.
HIGH COST OF TREATMENT
3. BONE MARROW TRANSPLANT INDUSTRY OUTLOOK
- BY TRANSPLANT TYPE
3.1. AUTOLOGOUS
BONE MARROW TRANSPLANT
3.2. ALLOGENEIC
BONE MARROW TRANSPLANT
4. BONE MARROW TRANSPLANT INDUSTRY OUTLOOK
- BY INDICATION
4.1. MULTIPLE
MYELOMA
4.2. ACUTE
LEUKEMIA
4.3. HODGKIN
LYMPHOMA
4.4. NON-HODGKIN
LYMPHOMA
4.5. SOLID
TUMORS
4.6. OTHER
INDICATION
5. BONE MARROW TRANSPLANT INDUSTRY OUTLOOK
- BY END-USER
5.1. MULTISPECIALTY
CLINICS
5.2. HOSPITALS
5.3. AMBULATORY
SURGICAL CENTERS
6. BONE
MARROW TRANSPLANT INDUSTRY – REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. COUNTRY
ANALYSIS
6.1.1.1. UNITED
STATES
6.1.1.2. CANADA
6.2. EUROPE
6.2.1. COUNTRY
ANALYSIS
6.2.1.1. THE
UNITED KINGDOM (UK)
6.2.1.2. FRANCE
6.2.1.3. GERMANY
6.2.1.4. SPAIN
6.2.1.5. ITALY
6.2.1.6. RUSSIA
6.2.1.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. COUNTRY
ANALYSIS
6.3.1.1. CHINA
6.3.1.2. INDIA
6.3.1.3. JAPAN
6.3.1.4. SOUTH
KOREA
6.3.1.5. ASEAN
COUNTRIES
6.3.1.6. AUSTRALIA
AND NEW ZEALAND
6.3.1.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. COUNTRY
ANALYSIS
6.4.1.1. BRAZIL
6.4.1.2. MEXICO
6.4.1.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA (MEA)
6.5.1. COUNTRY
ANALYSIS
6.5.1.1. SAUDI
ARABIA
6.5.1.2. TURKEY
6.5.1.3. UNITED
ARAB EMIRATES
6.5.1.4. SOUTH
AFRICA
6.5.1.5. REST
OF MIDDLE EAST AND AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. AFFYMETRIX,
INC. (ACQUIRED BY THERMOFISHER)
7.3. AGENDIA N.V.
7.4. AGILENT
TECHNOLOGIES, INC.
7.5. AMBRILIA
BIOPHARMA INC.
7.6. ASTELLAS
PHARMA INC.
7.7. DIADEXUS
INC. (ACQUIRED BY DIAZYME LABORATORIES)
7.8. ILLUMINA,
INC.
7.9. QIAGEN
N.V.
7.10.
ROCHE DIAGNOSTICS LTD
7.11.
SANOFI
7.12.
STRYKER CORPORATION
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE
1 GLOBAL BONE MARROW TRANSPLANT
MARKET BY REGION 2019-2027 ($ MILLION)
TABLE
2 GLOBAL BONE MARROW TRANSPLANT
MARKET BY TRANSPLANT TYPE 2019-2027 ($ MILLION)
TABLE
3 GLOBAL BONE MARROW TRANSPLANT
MARKET BY INDICATION 2019-2027 ($ MILLION)
TABLE
4 GLOBAL BONE MARROW TRANSPLANT
MARKET IN MULTIPLE MYELOMA BY TRANSPLANT TYPE 2019-2027 ($ MILLION)
TABLE
5 GLOBAL BONE MARROW TRANSPLANT
MARKET IN ACUTE LEUKEMIA BY TRANSPLANT TYPE 2019-2027 ($ MILLION)
TABLE
6 GLOBAL BONE MARROW TRANSPLANT
MARKET IN HODGKIN LYMPHOMA BY TRANSPLANT TYPE 2019-2027 ($ MILLION)
TABLE
7 GLOBAL BONE MARROW TRANSPLANT
MARKET IN NON-HODGKIN LYMPHOMA BY TRANSPLANT TYPE 2019-2027 ($ MILLION)
TABLE
8 GLOBAL BONE MARROW TRANSPLANT
MARKET IN SOLID TUMORS BY TRANSPLANT TYPE 2019-2027 ($ MILLION)
TABLE
9 GLOBAL BONE MARROW TRANSPLANT
MARKET, BY REGION 2019-2027($ MILLION)
TABLE
10 NORTH AMERICA BONE MARROW
TRANSPLANT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
11 EUROPE BONE MARROW TRANSPLANT
MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
12 ASIA-PACIFIC BONE MARROW
TRANSPLANT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
13 LATIN AMERICA BONE MARROW
TRANSPLANT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
14 MIDDLE EAST AND AFRICA BONE MARROW
TRANSPLANT MARKET 2019-2027 BY COUNTRY ($ MILLION)
FIGURE
1 BONE MARROW BLOOD COMPONENTS
FIGURE
2 GLOBAL BONE MARROW MARKET
TRANSPLANT 2019-2027 ($ MILLION)
FIGURE
3 DIFFERENT TYPES OF CANCERS MANAGED
BY BONE MARROW TRANSPLANT
FIGURE
4 ETHICAL ISSUES REQUIREMENTS IN BONE
MARROW TRANSPLANT
FIGURE
5 PHASES IN BONE MARROW TRANSPLANT
FIGURE
6 GLOBAL BONE MARROW TRANSPLANT
MARKET IN AUTOLOGOUS BONE MARROW TRANSPLANT 2019-2027 ($ MILLION)
FIGURE
7 GLOBAL BONE MARROW TRANSPLANT
MARKET IN ALLOGENIC BONE MARROW TRANSPLANT 2019-2027 ($ MILLION)
FIGURE
8 GLOBAL BONE MARROW TRANSPLANT
MARKET IN MULTIPLE MYELOMA 2019-2027 ($ MILLION)
FIGURE
9 GLOBAL BONE MARROW TRANSPLANT
MARKET IN ACUTE LEUKEMIA 2019-2027 ($ MILLION)
FIGURE
10 GLOBAL BONE MARROW TRANSPLANT MARKET
IN HODGKIN LYMPHOMA 2019-2027 ($ MILLION)
FIGURE
11 GLOBAL BONE MARROW TRANSPLANT MARKET
IN NON-HODGKIN LYMPHOMA 2019-2027 ($ MILLION)
FIGURE
12 GLOBAL BONE MARROW TRANSPLANT MARKET
IN SOLID TUMORS 2019-2027 ($ MILLION)
FIGURE
13 GLOBAL BONE MARROW TRANSPLANT MARKET
IN OTHER INDICATION 2019-2027 ($ MILLION)
FIGURE
14 GLOBAL BONE MARROW TRANSPLANT MARKET IN
MULTISPECIALTY CLINICS 2019-2027 ($ MILLION)
FIGURE
15 GLOBAL BONE MARROW TRANSPLANT MARKET
IN HOSPITALS 2019-2027 ($ MILLION)
FIGURE
16 GLOBAL BONE MARROW TRANSPLANT MARKET
IN AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
FIGURE
17 UNITED STATES BONE MARROW TRANSPLANT
MARKET 2019-2027 ($ MILLION)
FIGURE
18 CANADA BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
19 PERCENTAGE VISE DISTRIBUTION OF
VARIOUS CANCERS ENGLAND (2016)
FIGURE
20 THE UNITED KINGDOM BONE MARROW
TRANSPLANT MARKET 2019-2027 ($ MILLION)
FIGURE
21 FRANCE BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
22 GERMANY BONE MARROW TRANSPLANT MARKET
2019-2027 ($ MILLION)
FIGURE
23 SPAIN BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
24 ITALY BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
25 RUSSIA BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
26 REST OF EUROPE BONE MARROW TRANSPLANT
MARKET 2019-2027 ($ MILLION)
FIGURE
27 CHINA BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
28 INDIA BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
29 JAPAN BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
30 SOUTH KOREA BONE MARROW TRANSPLANT
MARKET 2019-2027 ($ MILLION)
FIGURE
31 ASEAN COUNTRIES
BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)
FIGURE 32 AUSTRALIA
AND NEW ZEALAND BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)
FIGURE
33 REST OF ASIA-PACIFIC BONE MARROW
TRANSPLANT MARKET 2019-2027 ($ MILLION)
FIGURE
34 BRAZIL BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
35 MEXICO BONE MARROW TRANSPLANT MARKET 2019-2027
($ MILLION)
FIGURE
36 REST OF LATIN AMERICA BONE MARROW
TRANSPLANT MARKET 2019-2027 ($ MILLION)
FIGURE
37 SAUDI ARABIA AMERICA BONE MARROW
TRANSPLANT MARKET 2019-2027 ($ MILLION)
FIGURE
38 TURKEY
BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)
FIGURE
39 UNITED ARAB EMIRATES BONE MARROW
TRANSPLANT MARKET 2019-2027 ($ MILLION)
FIGURE
40 SOUTH AFRICA BONE MARROW TRANSPLANT
MARKET 2019-2027 ($ MILLION)
FIGURE
41 REST OF MIDDLE EAST AND AFRICA BONE MARROW
TRANSPLANT MARKET 2019-2027 ($ MILLION)